Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-EN
Language French English
Date Updated 2022-04-19 2022-04-14
Drug Identification Number 02363356 02363356
Brand name EMEND IV EMEND IV
Common or Proper name fosaprepitant for injection fosaprepitant for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients FOSAPREPITANT FOSAPREPITANT
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 dose vial 1 dose vial
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-04-14 2022-04-14
Actual start date 2022-04-14 2022-04-14
Estimated end date 2022-04-22 2022-04-22
Actual end date 2022-04-19
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments